Accompanying study in a physician-initiated phase II clinical trial of anti-PD-1 antibody therapy for relapsed / progressive meningioma.
Not Applicable
Recruiting
- Conditions
- meningioma
- Registration Number
- JPRN-UMIN000036642
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 29
Inclusion Criteria
Not provided
Exclusion Criteria
patients who decline to be enroll in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method